Intco Medical Technology Co Ltd
SZSE:300677

Watchlist Manager
Intco Medical Technology Co Ltd Logo
Intco Medical Technology Co Ltd
SZSE:300677
Watchlist
Price: 57.02 CNY -1.32% Market Closed
Market Cap: ¥37.3B

P/E

21.9
Current
5%
Cheaper
vs 3-y average of 23

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
21.9
=
Market Cap
¥27.2B
/
Net Income
¥1.7B

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
21.9
=
Market Cap
¥27.2B
/
Net Income
¥1.7B

Valuation Scenarios

Intco Medical Technology Co Ltd is trading below its 3-year average

If P/E returns to its 3-Year Average (23), the stock would be worth ¥59.71 (5% upside from current price).

Statistics
Positive Scenarios
3/4
Maximum Downside
-36%
Maximum Upside
+53%
Average Upside
14%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple 21.9 ¥57.02
0%
3-Year Average 23 ¥59.71
+5%
5-Year Average 14.1 ¥36.74
-36%
Industry Average 33.5 ¥87.15
+53%
Country Average 29.6 ¥77.03
+35%

Forward P/E
Today’s price vs future net income

Today's Market Cap Net Income Forward P/E
¥27.2B
/
Oct 2025
¥1.7B
=
21.9
Current
¥27.2B
/
Dec 2025
¥1.4B
=
19.1
Forward
¥27.2B
/
Dec 2026
¥1.8B
=
15.3
Forward
¥27.2B
/
Dec 2027
¥2.1B
=
13.2
Forward

Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.

Market Distribution

In line with most companies in China
Percentile
39th
Based on 5 557 companies
39th percentile
21.9
Low
0 — 17.1
Typical Range
17.1 — 57.7
High
57.7 —
Distribution Statistics
China
Min 0
30th Percentile 17.1
Median 29.6
70th Percentile 57.7
Max 43 569.3

Intco Medical Technology Co Ltd
Glance View

Market Cap
37.3B CNY
Industry
Health Care

In the bustling industrial landscape of China, Intco Medical Technology Co., Ltd. has carved a distinctive niche as a significant player in the production and global distribution of disposable medical products. Established in 2009, the company has orchestrated its growth strategy by focusing on the manufacture of essential medical consumables like gloves, face masks, thermal plastics, and non-woven products. Intco's operations are adeptly integrated, with facilities strategically located to optimize manufacturing efficiencies and logistical ease, facilitating swift distribution to over 100 countries. This strategic footprint ensures that products are rapidly dispatched to meet the ever-increasing demands of global healthcare markets. Driving the company’s financial engine is its diversified product portfolio, tailored to cater to a wide array of healthcare needs, from hospitals to individual consumers who prioritize personal health safety. The company monetizes its offerings through a robust sales network, leveraging both direct sales channels and partnerships with global distributors. While the COVID-19 pandemic played a role in increasing demand for personal protective equipment, Intco has sustained its profitability through a commitment to quality and innovation, continuously expanding its research and development initiatives. By maintaining a balance between high-volume production and stringent quality control, Intco Medical Technology thrives as a cornerstone in the healthcare supply chain, adeptly navigating the dynamics of a rapidly evolving industry.

Intrinsic Value
18.98 CNY
Overvaluation 67%
Intrinsic Value
Price ¥57.02
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett